Globus Medical Return on Tangible Equity 2010-2022 | GMED

Current and historical return on tangible equity values for Globus Medical (GMED) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Globus Medical Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2022-09-30 $0.16B $1.53B 10.30%
2022-06-30 $0.16B $1.46B 10.38%
2022-03-31 $0.14B $1.54B 9.59%
2021-12-31 $0.15B $1.49B 10.45%
2021-09-30 $0.19B $1.48B 13.66%
2021-06-30 $0.18B $1.41B 14.15%
2021-03-31 $0.12B $1.33B 9.84%
2020-12-31 $0.10B $1.26B 8.61%
2020-09-30 $0.10B $1.21B 8.14%
2020-06-30 $0.09B $1.12B 7.75%
2020-03-31 $0.15B $1.15B 13.04%
2019-12-31 $0.16B $1.20B 14.01%
2019-09-30 $0.15B $1.13B 13.89%
2019-06-30 $0.14B $1.07B 14.29%
2019-03-31 $0.15B $1.03B 15.67%
2018-12-31 $0.16B $0.97B 17.33%
2018-09-30 $0.14B $0.93B 16.87%
2018-06-30 $0.14B $0.90B 16.80%
2018-03-31 $0.12B $0.82B 15.77%
2017-12-31 $0.11B $0.77B 14.92%
2017-09-30 $0.11B $0.73B 15.46%
2017-06-30 $0.11B $0.70B 16.01%
2017-03-31 $0.11B $0.70B 15.84%
2016-12-31 $0.10B $0.66B 16.16%
2016-09-30 $0.12B $0.63B 18.87%
2016-06-30 $0.12B $0.66B 19.53%
2016-03-31 $0.12B $0.62B 20.37%
2015-12-31 $0.11B $0.59B 21.12%
2015-09-30 $0.10B $0.55B 20.12%
2015-06-30 $0.10B $0.52B 19.94%
2015-03-31 $0.10B $0.49B 19.69%
2014-12-31 $0.09B $0.50B 19.19%
2014-09-30 $0.09B $0.51B 18.45%
2014-06-30 $0.08B $0.48B 18.62%
2014-03-31 $0.07B $0.45B 16.24%
2013-12-31 $0.07B $0.42B 16.71%
2013-09-30 $0.07B $0.42B 17.37%
2013-06-30 $0.06B $0.40B 17.29%
2013-03-31 $0.08B $0.38B 21.89%
2012-12-31 $0.07B $0.36B 22.95%
2012-09-30 $0.07B $0.34B 22.46%
2012-06-30 $0.07B $0.31B 31.85%
2012-03-31 $0.06B $0.28B 45.17%
2011-12-31 $0.06B $0.27B 84.53%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $7.483B $0.958B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00